Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
10,000
+219
+2% +$25.3K 0.01% 1344
2026
Q1
$1.17M Buy
9,781
+51
+0.5% +$6.69K 0.01% 1248
2025
Q4
$1.32M Sell
9,730
-693
-7% -$99.7K 0.01% 1163
2025
Q3
$1.54M Sell
10,423
-157
-1% -$21.8K 0.01% 1043
2025
Q2
$1.37M Sell
10,580
-3,846
-27% -$466K 0.01% 1039
2025
Q1
$1.72M Sell
14,426
-12,323
-46% -$1.53M 0.01% 842
2024
Q4
$3.26M Buy
26,749
+713
+3% +$90.1K 0.02% 676
2024
Q3
$3.3M Buy
26,036
+3,614
+16% +$484K 0.02% 666
2024
Q2
$2.97M Buy
+22,422
New +$3.05M 0.02% 647

Other funds holding XYL

Sanctuary Advisors's XYL Position: Q2 2026 in Review

Sanctuary Advisors increased its Xylem (XYL) stake by 2.2% in Q2 2026, buying an estimated $25.3K and bringing the position to 10,000 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #1344.

Sanctuary Advisors first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.3M in Q3 2024. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Sanctuary Advisors held 10,000 shares of Xylem worth $1.18M as of Q2 2026.
  • Sanctuary Advisors bought 219 Xylem shares in Q2 2026, an estimated $25.3K.
  • Xylem made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1344 holding.
  • Sanctuary Advisors first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Xylem position peaked at $3.3M in Q3 2024.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.